| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $30M | $28M | — | 6.3% | — |
| Op. Income | $9M | $6M | — | 68.6% | — |
| Gross Margin | 69.7% | 61.6% | — | 8.1pp | — |
| Net Margin | 24.7% | 15.3% | — | 9.4pp | — |
| EPS (Diluted) | $0.51 | $0.30 | — | 70.0% | — |
| Free Cash Flow | $0 | -$12M | — | 100.0% | — |
| Item | Amount |
|---|---|
| REVENUE | $30M |
| Cost of Revenue | $9M |
| GROSS PROFIT | $21M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $7M |
| SG&A Expenses | $7M |
| Other Expenses | $5M |
| Operating Expenses | $11M |
| Cost & Expenses | $21M |
| OPERATING INCOME | $9M |
| Interest Income | $23M |
| Interest Expense | $9M |
| Other Income/Expenses | $18.0K |
| INCOME BEFORE TAX | $9M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | -$18.0K |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $0 |
| EBIT | $9M |
| EBITDA | $9M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $30M |
| Cost of Revenue | $9M |
| GROSS PROFIT | $21M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $7M |
| SG&A Expenses | $7M |
| Other Expenses | $5M |
| Operating Expenses | $11M |
| Cost & Expenses | $21M |
| OPERATING INCOME | $9M |
| Interest Income | $23M |
| Interest Expense | $9M |
| Other Income/Expenses | $18.0K |
| INCOME BEFORE TAX | $9M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | -$18.0K |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $0 |
| EBIT | $9M |
| EBITDA | $9M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $7M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$7M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | -$103M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $5M |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $5M |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $11M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | -$11M |
| TOTAL NON-CURRENT ASSETS | $0 |
| TOTAL ASSETS | $1.4B |
| Account Payables | $0 |
| Short-Term Debt | $371.0K |
| Deferred Revenue | $0 |
| Other Current Liabilities | $6M |
| TOTAL CURRENT LIABILITIES | $6M |
| Long-Term Debt | $32M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $242M |
| TOTAL NON-CURRENT LIABILITIES | $279M |
| TOTAL LIABILITIES | $1.2B |
| Common Stock | $1.0K |
| Additional Paid-In Capital | $80M |
| Retained Earnings | $85M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$17.0K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $166M |
| Minority Interest | $0 |
| TOTAL EQUITY | $166M |
| TOTAL LIABILITIES & EQUITY | $1.4B |
| Total Debt | $38M |
| Net Debt | $33M |
